As part of scientific exchange, Novartis is providing the most recent abstract(s) accepted by the referenced medical congress. The scientific information may include data/information on investigational use(s) of compounds/drugs that efficacy and safety have not been established. Information available on this website is not intended to promote or otherwise commercialize (directly or indirectly) any off-label or unapproved uses of Novartis products.
Not all content may be available. Dependent on congress policy, links to the original poster/slide deck may only be available via the congress site where registration may be needed to access.
Content to be used in accordance with local CPO guidelines
Substantial Increases in Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size With Oral Iptacopan Monotherapy Confirms Control of Hemolysis in Complement Inhibitor-Naive PNH Patients
Régis Peffault de Latour
Presentation # MDS-278 – Poster
Sep 06, 2023 | 06:00 PM - 07:00 PM CT
Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia
Antonio M Risitano
Presentation # MDS-273 – Poster
Sep 06, 2023 | 06:00 PM - 07:00 PM CT
A Systematic Literature Review of Clinical Response Among Patients with Paroxysmal Nocturnal Hemoglobinuria in Clinical Trials and Real-World Settings
Anem Waheed
Presentation # MDS-576 – Poster
Sep 06, 2023 | 06:00 PM - 07:00 PM CT
